Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.5500 (2.01%) ($41.5500 - $41.5500) on Thu. Aug. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.86% (three month average) | RSI | 38 | Latest Price | $41.5500(2.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.5% a day on average for past five trading days. | Weekly Trend | HALO declines -1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(48%) IWC(45%) IWN(44%) | Factors Impacting HALO price | HALO will decline at least -0.93% in a week (0% probabilities). VIXM(-29%) VXX(-11%) UUP(-11%) GLD(-2%) TBT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.93% (StdDev 1.86%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $40.86(1.69%) | 10 Day Moving Average | $40.72(2.04%) | 20 Day Moving Average | $41.27(0.68%) | To recent high | -10.4% | To recent low | 7% | Market Cap | $5.679b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |